Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP907127.RAzSBq5kIlimGXh__4dVkdzhm8vxzEPpRsftiDeTjVCg4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP907127.RAzSBq5kIlimGXh__4dVkdzhm8vxzEPpRsftiDeTjVCg4130_assertion type Assertion NP907127.RAzSBq5kIlimGXh__4dVkdzhm8vxzEPpRsftiDeTjVCg4130_head.
- NP907127.RAzSBq5kIlimGXh__4dVkdzhm8vxzEPpRsftiDeTjVCg4130_assertion wasGeneratedBy ECO_0000203 NP907127.RAzSBq5kIlimGXh__4dVkdzhm8vxzEPpRsftiDeTjVCg4130_provenance.
- NP907127.RAzSBq5kIlimGXh__4dVkdzhm8vxzEPpRsftiDeTjVCg4130_assertion wasDerivedFrom befree-20150227 NP907127.RAzSBq5kIlimGXh__4dVkdzhm8vxzEPpRsftiDeTjVCg4130_provenance.
- NP907127.RAzSBq5kIlimGXh__4dVkdzhm8vxzEPpRsftiDeTjVCg4130_assertion SIO_000772 21886843 NP907127.RAzSBq5kIlimGXh__4dVkdzhm8vxzEPpRsftiDeTjVCg4130_provenance.
- NP907127.RAzSBq5kIlimGXh__4dVkdzhm8vxzEPpRsftiDeTjVCg4130_assertion evidence source_evidence_literature NP907127.RAzSBq5kIlimGXh__4dVkdzhm8vxzEPpRsftiDeTjVCg4130_provenance.
- NP907127.RAzSBq5kIlimGXh__4dVkdzhm8vxzEPpRsftiDeTjVCg4130_assertion description "[As observed in CHC patients, serum levels of miR-122, miR-34a and miR-16 were significantly higher in NAFLD patients than in controls, while miR-21 levels were unchanged.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP907127.RAzSBq5kIlimGXh__4dVkdzhm8vxzEPpRsftiDeTjVCg4130_provenance.